BiondVax Pharmaceuticals (BVXV) stock forecast for 2024. Forecast tables and graphs.

BiondVax Pharmaceuticals (BVXV) stock forecast for 2024

Last update: 05-19-2022, 14:23

Sector: Healthcare

The share price of BiondVax Pharmaceuticals Ltd. (BVXV) now

What analysts predict:: $9.5

52-week high/low: $4.19 / $1

50/200 Day Moving Average: $1.46 / $1.858

This figure corresponds to the average price over the previous 50/200 days. For BiondVax Pharmaceuticals stocks, the 50-day moving average is the support level today.

For BiondVax Pharmaceuticals stocks, the 200-day moving average is the resistance level today.

Are you interested in BiondVax Pharmaceuticals stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BiondVax Pharmaceuticals stock price in 2024. How much will one BiondVax Pharmaceuticals share be worth in 2024?

Is it worth taking profit / loss on BiondVax Pharmaceuticals stock now or waiting? What are analysts' forecasts for BiondVax Pharmaceuticals stock?

We forecast BiondVax Pharmaceuticals stock performance using neural networks based on historical data on BiondVax Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

The BiondVax Pharmaceuticals stock prediction results are shown below and presented as a graph, table and text information.

BiondVax Pharmaceuticals stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for BiondVax Pharmaceuticals analysts is $9.5.

Today 200 Day Moving Average is the resistance level (1.858 $).

50 Day Moving Average is the support level (1.46 $).




Historical and forecast chart of BiondVax Pharmaceuticals stock

The chart below shows the historical price of BiondVax Pharmaceuticals stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BiondVax Pharmaceuticals stock price can be found in the table below.

BiondVax Pharmaceuticals (BVXV) Forecast for 2024

Month Target Pes. Opt. Vol., %
Jan 0.97 0.88 1.04 15.32 %
Feb 0.72 0.56 0.76 26.45 %
Mar 0.68 0.56 0.82 32.63 %
Apr 0.63 0.53 0.72 26.71 %
May 0.68 0.57 0.82 30.69 %
Jun 0.73 0.69 0.80 14.46 %
Jul 0.69 0.64 0.74 13.80 %
Aug 0.74 0.68 0.87 21.98 %
Sep 0.66 0.54 0.73 26.33 %
Oct 0.64 0.59 0.78 25.28 %
Nov 0.68 0.57 0.80 29.37 %
Dec 0.56 0.51 0.68 25.16 %

BiondVax Pharmaceuticals information and performance

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company developing a universal influenza vaccine called M-001. BiondVax is a publicly traded company, listed on the NASDAQ. The vaccine technology was invented in the 1990s at the Weizmann Institute of Science in the laboratory of Ruth Arnon, and was licensed to BiondVax in 2003.

BiondVax Pharmaceuticals Address

JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, IL

Market Capitalization: 25 145 400 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.296

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: 2.825

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 18626200

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

BiondVax Pharmaceuticals price target for 2021 by month


Target values for the price of one BiondVax Pharmaceuticals share for Jan 2024.

The weighted average target price per BiondVax Pharmaceuticals share in Jan 2024 is: 0.97. In Jan, the negative dynamics for Momo shares will prevail with possible monthly volatility of 15.319% volatility is expected.

Pessimistic target level: 0.88

Optimistic target level: 1.04


Target values for the price of one BiondVax Pharmaceuticals share for Feb 2024.

The weighted average target price per BiondVax Pharmaceuticals share in Feb 2024 is: 0.72. In Feb, the negative dynamics for Momo shares will prevail with possible monthly volatility of 26.445% volatility is expected.

Pessimistic target level: 0.56

Optimistic target level: 0.76


Target values for the price of one BiondVax Pharmaceuticals share for Mar 2024.

The weighted average target price per BiondVax Pharmaceuticals share in Mar 2024 is: 0.68. In Mar, the negative dynamics for Momo shares will prevail with possible monthly volatility of 32.628% volatility is expected.

Pessimistic target level: 0.56

Optimistic target level: 0.82


Target values for the price of one BiondVax Pharmaceuticals share for Apr 2024.

The weighted average target price per BiondVax Pharmaceuticals share in Apr 2024 is: 0.63. In Apr, the negative dynamics for Momo shares will prevail with possible monthly volatility of 26.706% volatility is expected.

Pessimistic target level: 0.53

Optimistic target level: 0.72


Target values for the price of one BiondVax Pharmaceuticals share for May 2024.

The weighted average target price per BiondVax Pharmaceuticals share in May 2024 is: 0.68. In May, the positive dynamics for Momo shares will prevail with possible monthly volatility of 30.688% volatility is expected.

Pessimistic target level: 0.57

Optimistic target level: 0.82


Target values for the price of one BiondVax Pharmaceuticals share for Jun 2024.

The weighted average target price per BiondVax Pharmaceuticals share in Jun 2024 is: 0.73. In Jun, the positive dynamics for Momo shares will prevail with possible monthly volatility of 14.462% volatility is expected.

Pessimistic target level: 0.69

Optimistic target level: 0.80


Target values for the price of one BiondVax Pharmaceuticals share for Jul 2024.

The weighted average target price per BiondVax Pharmaceuticals share in Jul 2024 is: 0.69. In Jul, the negative dynamics for Momo shares will prevail with possible monthly volatility of 13.797% volatility is expected.

Pessimistic target level: 0.64

Optimistic target level: 0.74


Target values for the price of one BiondVax Pharmaceuticals share for Aug 2024.

The weighted average target price per BiondVax Pharmaceuticals share in Aug 2024 is: 0.74. In Aug, the positive dynamics for Momo shares will prevail with possible monthly volatility of 21.978% volatility is expected.

Pessimistic target level: 0.68

Optimistic target level: 0.87


Target values for the price of one BiondVax Pharmaceuticals share for Sep 2024.

The weighted average target price per BiondVax Pharmaceuticals share in Sep 2024 is: 0.66. In Sep, the negative dynamics for Momo shares will prevail with possible monthly volatility of 26.333% volatility is expected.

Pessimistic target level: 0.54

Optimistic target level: 0.73


Target values for the price of one BiondVax Pharmaceuticals share for Oct 2024.

The weighted average target price per BiondVax Pharmaceuticals share in Oct 2024 is: 0.64. In Oct, the negative dynamics for Momo shares will prevail with possible monthly volatility of 25.279% volatility is expected.

Pessimistic target level: 0.59

Optimistic target level: 0.78


Target values for the price of one BiondVax Pharmaceuticals share for Nov 2024.

The weighted average target price per BiondVax Pharmaceuticals share in Nov 2024 is: 0.68. In Nov, the positive dynamics for Momo shares will prevail with possible monthly volatility of 29.374% volatility is expected.

Pessimistic target level: 0.57

Optimistic target level: 0.80


Target values for the price of one BiondVax Pharmaceuticals share for Dec 2024.

The weighted average target price per BiondVax Pharmaceuticals share in Dec 2024 is: 0.56. In Dec, the negative dynamics for Momo shares will prevail with possible monthly volatility of 25.165% volatility is expected.

Pessimistic target level: 0.51

Optimistic target level: 0.68




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.